Opendata, web and dolomites

HTMD

Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HTMD project word cloud

Explore the words cloud of the HTMD project. It provides you a very rough idea of what is the project "HTMD" about.

gain    computationally    proposes    interfaces    substantially    significantly    silico    preparations    accuracy    description    simulations    resource    htmd    translating    companies    expensive    molecular    instrument    drugs    interact    barrier    competitiveness    limits    looks    pcr    provides    productivity    simulation    combines    solution    positioned    environment    industry    acellera    drug    workflows    larger    throughput    reduce    candidate    identification    clinical    demonstration    viability    optimized    cloud    invest    platform    feasibility    subsequent    dynamics    approximately    launch    trl    inform    biological    prototyping    degree    proprietary    proposing    rational    interactions    resolution    unprecedented    pharmaceutical    sme    virtualizing    uniquely    md    approved    1000m    traction    disruptive    speed    global    entry    complexity    progress    spending    computational    accurate    market    beginning    unnecessary    discovery    leader    ready    pace   

Project "HTMD" data sheet

The following table provides information about the project.

Coordinator
ACELLERA LABS SL 

Organization address
address: C/ DELS PINZON 19 2-4
city: BARCELONA
postcode: 8003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACELLERA LABS SL ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain competitiveness. In-silico computational methods are beginning to gain traction in the progress towards more rational drug discovery workflows. Among the methods available, molecular dynamics (MD) provides the most accurate and useful description of molecular interactions, but the current state of the art has both a high degree of unnecessary technical complexity, and is computationally expensive. Together, these two factors have produced a high barrier to entry that substantially limits research productivity.Acellera looks to address these issues by proposing a cloud application platform for high-throughput MD (HTMD) simulations. This computational platform combines proprietary simulation technology - optimized for speed and simulation throughput – and user-friendly interfaces in a cloud environment to provide a novel resource for drug candidate identification. HTMD, which allows understanding with an unprecedented degree of resolution and accuracy how drugs interact with their biological targets, can significantly reduce the cost of pre-clinical research (PCR) by virtualizing key steps. It is currently estimated that pharmaceutical companies invest approximately 1000M Euro per approved drug. As a global leader in the development of technology for high-throughput molecular dynamics, Acellera is uniquely positioned to bring this disruptive computational technology to the market. The HTMD platform is ready for prototyping in an operational environment (TRL 6). Acellera proposes a Phase 1 SME Instrument to support the execution of a feasibility study into the market viability of the HTMD solution for pre-clinical research. Results of the study will be used to inform preparations for a larger-scale demonstration in Phase 2 and for the subsequent market launch.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HTMD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HTMD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

Digital Iris (2018)

Bringing the human being into the digital loop

Read More  

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More